CBIZ Q2 Earnings Plunge 56%, Material Weaknesses Disclosed, Guidance Pulled Amid $5B Buyout
CBZ has more than doubled off its 52-week low of $24.29.
Summary
CBIZ reported a 55.6% drop in Q2 net income, withdrew 2026 guidance, and disclosed two material weaknesses in internal controls, including a restatement of Q1 results. The filing comes amid a pending $5 billion all-cash acquisition at $55.00 per share.
Key Events · Earnings and Guidance · CBZ
-
Q2 Net Income Plunges 55.6%
Net income fell to $18.6 million from $41.9 million a year ago, driven by higher operating expenses and a $7.2 million legal settlement loss.
-
2026 Guidance Withdrawn
Management pulled its full-year outlook, citing uncertainty related to the pending acquisition by Grant Thornton Advisors.
-
Two Material Weaknesses Disclosed
The company identified material weaknesses in internal controls over ESPP share administration and goodwill reassignment, leading to a restatement of Q1 2026 results.
-
$57.2M Gain from Marcum Working Capital Adjustment
A one-time gain from finalizing the Marcum acquisition working capital partially offset the earnings decline.
Analysis · CBZ · Trade & Services
CBIZ's Q2 2026 10-Q reveals a sharp 55.6% drop in net income to $18.6 million, driven by higher operating costs and a $7.2 million legal settlement. The company withdrew its full-year 2026 guidance, citing uncertainty from the pending $55/share acquisition by Grant Thornton. Critically, management disclosed two material weaknesses in internal controls — one related to an ESPP share over-issuance that forced a restatement of Q1 results, and another involving goodwill reassignment. These control failures, combined with the earnings miss and guidance pull, raise serious governance concerns even as the all-cash buyout at $55.00 per share provides a floor for the stock.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 46.1% of the 284 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CBZ was trading at $55.08 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $24.29 to $67.24. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.